• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Toric phakic IOLs give good results in high myopia, hyperopia

Article

When the lens was implanted in patients with hyperopia, very good results were obtained in patients with up to 12 D of refractive error.

Related Videos
Video 1 - "Challenging the Definition of Dry Eye- Interpreting Diagnostic Tests"
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Related Content
Adaptilens closes Series A financing round of $17.5 million to help drive development of the company's Accommodating Intraocular Lens

Adaptilens closes Series A financing round of $17.5 million to help drive development of the company's Accommodating Intraocular Lens

Article
Claris Bio's journey toward treating neurotrophic keratitis

Claris Bio's journey toward treating neurotrophic keratitis

Podcast
Study: Prevention of age-related truncation of γ-glutamylcysteine ligase catalytic subunit delays cataract formation

Study: Prevention of age-related truncation of γ-glutamylcysteine ligase catalytic subunit delays cataract formation

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Aurion Biotech completes dosing of all subjects in Phase 1/2 CLARA trial

Aurion Biotech completes dosing of all subjects in Phase 1/2 CLARA trial

Article
Companies prepare to unveil research at ARVO 2024 conference

Companies prepare to unveil research at ARVO 2024 conference

Article
© 2024 MJH Life Sciences

All rights reserved.